Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodological issues associated with tumor marker development. Biostatistical aspects.

Faraggi1, Kramar

  • 1Department of Statistics, University of Haifa, Haifa, Israel

Urologic Oncology
|September 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Making ends meet: String unification and low-energy data.

Physical review letters·1995
Same author

Vacuum Structure and Spectrum of N=2 Supersymmetric SU(n) Gauge Theory.

Physical review letters·1995
Same author

Naturalness of three generations in free fermionic Z2n

Physical review. D, Particles and fields·1993
Same author

Superheavy spectrum and supersymmetric grand unification.

Physical review. D, Particles and fields·1993
Same author

Yukawa couplings in superstring-derived standardlike models.

Physical review. D, Particles and fields·1993
Same author

Fractional charges in a superstring-derived standardlike model.

Physical review. D, Particles and fields·1992
Same journal

Does size matter? A national analysis of patterns of adjuvant immunotherapy receipt and tumor size-dependent survival in pT3N0M0 clear cell renal cell carcinoma.

Urologic oncology·2026
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
See all related articles

Conflicting tumor marker research results are often due to statistical multiplicity. This study reviews Receiver Operating Characteristic (ROC) curve analysis for marker evaluation and its extension for multiple markers.

Area of Science:

  • Clinical research
  • Biostatistics
  • Biomarker discovery

Background:

  • Identifying prognostic markers is crucial in clinical research.
  • Conflicting results in tumor marker studies cause confusion.
  • Statistical multiplicity is a key reason for these discrepancies.

Purpose of the Study:

  • To address the issue of multiplicity in tumor marker research.
  • To review Receiver Operating Characteristic (ROC) curve analysis for evaluating marker performance.
  • To present an extension of ROC analysis for multiple markers.

Main Methods:

  • Discussion of the statistical problem of multiplicity.
  • Review of ROC curve and area under the curve (AUC) for diagnostic accuracy.
  • Development of an extended ROC analysis framework for multi-marker scenarios.

Related Experiment Videos

Main Results:

  • Multiplicity is identified as a primary source of conflicting tumor marker data.
  • ROC analysis provides a robust method for assessing a marker's ability to differentiate populations.
  • The proposed extension enhances ROC analysis for evaluating multiple prognostic markers.

Conclusions:

  • Statistical methods like addressing multiplicity and ROC analysis are vital for reliable biomarker research.
  • Proper statistical evaluation is necessary to reduce confusion in tumor marker effectiveness data.
  • The extended ROC analysis offers a valuable tool for assessing combined marker performance in disease prognosis.